JPH06507565A - IVF methods and devices - Google Patents
IVF methods and devicesInfo
- Publication number
- JPH06507565A JPH06507565A JP5500135A JP50013592A JPH06507565A JP H06507565 A JPH06507565 A JP H06507565A JP 5500135 A JP5500135 A JP 5500135A JP 50013592 A JP50013592 A JP 50013592A JP H06507565 A JPH06507565 A JP H06507565A
- Authority
- JP
- Japan
- Prior art keywords
- oocyte
- chamber
- culture dish
- oocytes
- droplet
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Pending
Links
Classifications
-
- B—PERFORMING OPERATIONS; TRANSPORTING
- B01—PHYSICAL OR CHEMICAL PROCESSES OR APPARATUS IN GENERAL
- B01L—CHEMICAL OR PHYSICAL LABORATORY APPARATUS FOR GENERAL USE
- B01L3/00—Containers or dishes for laboratory use, e.g. laboratory glassware; Droppers
- B01L3/50—Containers for the purpose of retaining a material to be analysed, e.g. test tubes
- B01L3/502—Containers for the purpose of retaining a material to be analysed, e.g. test tubes with fluid transport, e.g. in multi-compartment structures
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12M—APPARATUS FOR ENZYMOLOGY OR MICROBIOLOGY; APPARATUS FOR CULTURING MICROORGANISMS FOR PRODUCING BIOMASS, FOR GROWING CELLS OR FOR OBTAINING FERMENTATION OR METABOLIC PRODUCTS, i.e. BIOREACTORS OR FERMENTERS
- C12M21/00—Bioreactors or fermenters specially adapted for specific uses
- C12M21/06—Bioreactors or fermenters specially adapted for specific uses for in vitro fertilization
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12M—APPARATUS FOR ENZYMOLOGY OR MICROBIOLOGY; APPARATUS FOR CULTURING MICROORGANISMS FOR PRODUCING BIOMASS, FOR GROWING CELLS OR FOR OBTAINING FERMENTATION OR METABOLIC PRODUCTS, i.e. BIOREACTORS OR FERMENTERS
- C12M23/00—Constructional details, e.g. recesses, hinges
- C12M23/02—Form or structure of the vessel
- C12M23/10—Petri dish
Landscapes
- Health & Medical Sciences (AREA)
- Chemical & Material Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- Wood Science & Technology (AREA)
- Organic Chemistry (AREA)
- Zoology (AREA)
- Engineering & Computer Science (AREA)
- Bioinformatics & Cheminformatics (AREA)
- General Health & Medical Sciences (AREA)
- Genetics & Genomics (AREA)
- Clinical Laboratory Science (AREA)
- Biotechnology (AREA)
- Microbiology (AREA)
- Sustainable Development (AREA)
- Biomedical Technology (AREA)
- Biochemistry (AREA)
- General Engineering & Computer Science (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Hematology (AREA)
- Analytical Chemistry (AREA)
- Molecular Biology (AREA)
- Micro-Organisms Or Cultivation Processes Thereof (AREA)
Abstract
(57)【要約】本公報は電子出願前の出願データであるため要約のデータは記録されません。 (57) [Summary] This bulletin contains application data before electronic filing, so abstract data is not recorded.
Description
【発明の詳細な説明】 体外受精方法および装置 発明の背景 本発明は体外(in vitro)受精の方法および装置に関する。[Detailed description of the invention] IVF methods and devices Background of the invention The present invention relates to methods and devices for in vitro fertilization.
ヒトと動物の不妊は、多くの原因から起こり得る。そしてその不妊は、少ない精 子数、低い精子の運動性、および低い割合の生存可能な運動精子に関連すること が多い。これらの問題を克服する1つの手法は、体外受精(rIVF」)、すな わち、体外の制御され観察できる環境における精子と卵母細胞の結合である。Infertility in humans and animals can result from many causes. And that infertility is caused by a lack of sperm. associated with offspring number, low sperm motility, and low percentage of viable motile sperm There are many. One technique to overcome these problems is through in vitro fertilization (rIVF), or That is, the union of sperm and oocytes in a controlled and observable environment outside the body.
現在実施されているように、体外受精は一般的に、パーコル勾配または「スイム −アップ(Swim−Up)Jのような方法により不健康精子または非運動精子 からの健康運動精子の前分離を含む(ローファー等、不妊において、サーベル、 M、 M、出版、アブレトン&5ンク(1990) )。As currently practiced, IVF is generally performed using a Percoll gradient or “swim” method. - Unhealthy or non-motile sperm by methods such as Swim-Up J Including pre-separation of healthy motile sperm from (e.g. loafers, sabers, M., M. Publishing, Abreton & 5ink (1990)).
そのような分別工程は、精子が通常のものである場合(例えば、女性の生殖系の 病理学による不妊)を含む全ての場合に行なわれる。普通の精子の試料でさえ、 がなりの数の非運動精子または死んだ精子および上皮細胞を含有するためにこの 基準がとられ、これらの外来性細胞は、運動精子と卵子の相互作用を妨害するこ とがある。しがしながら、望ましくない精子の除去に加え、これらの精子の分別 技術によって、同様にかなりの運動精子が損失することにもなり、それゆえ、体 外受精の失敗となり得ることもあるそれ自身の問題を引き起こす。Such a fractionation step may be useful if the sperm are normal (e.g. from the female reproductive system). It is performed in all cases including pathological infertility). Even a normal sperm sample This is due to the fact that it contains a large number of non-motile or dead spermatozoa and epithelial cells. Standards have been established to ensure that these foreign cells cannot interfere with the interaction of motile sperm and eggs. There is. However, in addition to the removal of undesirable spermatozoa, the separation of these spermatozoa The technique also results in a significant loss of motile sperm and therefore It poses its own problems which can lead to failure of IVF.
使用する精子分画を一度得ると、その精子を、液体培地中に少数の卵母細胞(一 般的に1から2)を含有する試料皿に加える。動物研究により、非常に少量の液 体培地または「微小小滴(microdrops)J中への精液注入は、卵子: 精子の相互作用を最大にし、受精に必要な精子:卵子比率を最少にするので、好 ましいものである。(バビスター、J、Exp、 Zoo 1.210 :25 9−264 (1979))。しかしながら、ヒトのIVFにおいては、微小小 滴は、蒸発によるpHの急速な変動および/または容量モル濃度の変化に晒され るので、そのような小滴は用いられない。それゆえ、標準IVF方法には通常2 ミリリツトルの培地中における卵子の受精が必要である。ローファー等。Once you have obtained the sperm fraction to be used, you can place the sperm into a small number of oocytes (one) in a liquid medium. Generally 1 to 2) is added to the sample dish containing 1 to 2). Animal studies have shown that very small amounts of fluid Injection of semen into the body medium or "microdrops" produces eggs: It is preferred because it maximizes sperm interaction and minimizes the sperm:egg ratio required for fertilization. It's a beautiful thing. (Bavistar, J, Exp, Zoo 1.210:25 9-264 (1979)). However, in human IVF, minute The droplets are exposed to rapid fluctuations in pH and/or changes in molarity due to evaporation. Therefore, such droplets are not used. Therefore, standard IVF methods usually include 2 Fertilization of eggs in milliliters of medium is required. Loafer et al.
これらの比較的大量の培地を用いると、受精を確実にするために大量の精子(1 −2XlO’以上)による受精が必要となる。しかしながら、精子試料が異常な 場合、または多くの卵子が得られる場合には、分別中の損失により、続いての受 精のための運動精子の数が不十分となることがある。この問題は、精子の数が低 い場合、および/または試料中の運動精子の比率が低い場合に、特に重大である 。These relatively large volumes of medium allow for large numbers of spermatozoa (1 -2XlO' or higher) is required. However, if the sperm sample is abnormal If a large number of oocytes are obtained, or if many oocytes are obtained, losses during sorting may result in There may be an insufficient number of motile sperm for ejaculation. This problem is caused by low sperm count. This is particularly important when the number of motile spermatozoa .
それゆえ、体外受精技術においては、精子の前分別工程を必要とせずに高い受精 能率を供することが必要とされている。本発明の目的は、この必要性を満たす方 法および装置を提供することにある。Therefore, in vitro fertilization techniques can achieve high fertilization rates without the need for a pre-fractionation step of spermatozoa. There is a need to provide efficiency. The purpose of the present invention is to meet this need. The purpose is to provide methods and equipment.
発明の概要 本発明によると、受精せしめられる卵母細胞を、受精培地の小滴の周囲または中 央に配された個々の低容積の卵母細胞室中に配する場合に、高能率の受精が達成 される。次いで精子試料、特に未分別精子試料を、小滴の中央、または修正した 中央を囲む周囲のくぼみに配する。運動精子はこの環境において卵母細胞に向か って敏速に動く傾向にあり、それゆえ、非運動精子からの運動精子のin 5i tU分離となる。卵母細胞室(chambers)に進入する精子による受精は 、低容積の室のために極めて容易である。Summary of the invention According to the invention, the oocytes to be fertilized are placed around or in a droplet of fertilization medium. High efficiency of fertilization achieved when placed in centrally located individual low volume oocyte chambers be done. The sperm sample, especially the unsorted sperm sample, is then placed in the center of the droplet, or fixed Place it in the hollow surrounding the center. Motile sperm move toward the oocyte in this environment. Therefore, the in5i of motile sperm from non-motile sperm This results in tU separation. Fertilization by sperm entering the oocyte chambers , is extremely easy for low volume chambers.
この受精方法は好ましくは、特にこの目的のために設計された培養皿中で行なわ れる。そのような培養皿は、皿の底部の内面に形成された複数の卵母細胞室を有 する。各卵母細胞室は、受精せしめられる卵母細胞の容積を超えるが、容易な受 精となるのに十分に小さい容積を有する。一般的に、卵母細胞室は、卵母細胞の 容積を800%から2.000%上回る容積を有する。この卵母細胞室は、0. 5から3cmの直径を有する皿の中央円形領域の周囲または中央プラトー領域に 配してもよい。This fertilization method is preferably carried out in culture dishes specifically designed for this purpose. It will be done. Such culture dishes have multiple oocyte chambers formed on the inner surface of the bottom of the dish. do. Each oocyte chamber exceeds the volume of the oocyte to be fertilized, but It has a small enough volume to be very small. Generally, the oocyte chamber is It has a volume that exceeds the volume by 800% to 2.000%. This oocyte chamber is 0. Around the central circular area of the dish with a diameter of 5 to 3 cm or in the central plateau area May be arranged.
第1図は、微小小滴の周囲を造形することにより卵母細胞室を形成した本発明の 実施態様を示す。Figure 1 shows the present invention in which an oocyte chamber is formed by modeling the periphery of a microdroplet. An embodiment is shown.
第2図は、本発明による培養皿の上面図を示す。FIG. 2 shows a top view of a culture dish according to the invention.
第3図は、本発明による培養皿の断面図を示す。FIG. 3 shows a cross-sectional view of a culture dish according to the invention.
第4図は、T形状の案内部材の断面図を示す。FIG. 4 shows a sectional view of the T-shaped guide member.
第5図は、本発明による培養皿の断面図を示す。FIG. 5 shows a cross-sectional view of a culture dish according to the invention.
発明の詳細な説明 本発明は、1段階方法による低容積の受精培地内の精子の分離と卵母細胞の単離 の両方を提供する。この方法の能率は、第1図に示したような原型の受精微小室 を用いて説明する。Detailed description of the invention The present invention describes the separation of spermatozoa and isolation of oocytes in a low volume of fertilization medium by a one-step method. Provide both. The efficiency of this method is based on the original fertilization microchamber shown in Figure 1. Explain using.
第1図において、培養皿を上から示す。この皿は、皿の金縁に亘る側面部1およ び底部2からなる。底部2の内面の中央に培養培地3の微小小滴を配し、皿表面 の接着特性を活用することにより卵母細胞室4を形成し、プラスチック微量ピペ ットチップを用いてこの形状に微小小滴を形成した。培養培地のリング5を微小 小滴の回りに配し、培地の通路6を形成して各卵母細胞室4を培養培地のリング 5に連結した。実験装置の様々な部分の寸法を表1に示す。In FIG. 1, the culture dish is shown from above. This plate has side parts 1 and 1 extending over the golden edge of the plate. It consists of a bottom part 2 and a bottom part 2. A microdroplet of culture medium 3 is placed in the center of the inner surface of the bottom part 2, and the surface of the dish is Form the oocyte chamber 4 by utilizing the adhesive properties of the plastic micropipette. Microdroplets were formed in this shape using a cut tip. Microscopic ring 5 of culture medium A ring of culture medium is placed around each oocyte chamber 4 to form a medium passageway 6. Connected to 5. The dimensions of various parts of the experimental setup are shown in Table 1.
表1.第1図の実験例の寸法 この設計の能率を試験するために、マウスの卵母細胞(約80μMの直径を有す る)を培地の微小小滴中に形成された4つの卵母細胞室のそれぞれに配し、未分 別冷凍−解凍マウス精子を微小小滴の中央に加え、上面に亘って油滴を配して培 地を正しい位置に保持した。物質は、中央微小小′a3から通路6を通じて外側 のリング5に流動する傾向にあり、この流動により卵母細胞を卵母細胞室内の適 性位置に保持する。体外受精のためのこの設計を用−)た結果、受精能率が5倍 に増大した。Table 1. Dimensions of the experimental example in Figure 1 To test the efficiency of this design, mouse oocytes (with a diameter of approximately 80 μM) ) was placed in each of the four oocyte chambers formed in a microdroplet of medium, and the undivided Separately frozen-thawed mouse sperm was added to the center of the microdroplet, and an oil droplet was placed over the top surface. held the ground in place. The substance is transferred from the central microscopic area 'a3 to the outside through the passage 6. The flow tends to move the oocyte into the ring 5 of the oocyte chamber. hold in sexual position. Using this design for in vitro fertilization, fertilization efficiency was increased by 5 times. It increased to
卵母細胞室と通路を製造するいくつかの技術を必要とし、その方法には時間がか かるので、各使用ための「注文」体外受精器の個々の構成は、実際的ではない。The method requires several techniques to manufacture oocyte chambers and passageways and is time consuming. Individual configurations of "custom" IVF devices for each use are therefore impractical.
さらに、中央微小小滴と外側リングの間の不完全に釣り合った表面張力が卵母細 胞を損傷し得ることが分かった。それゆえ、上述したマウス実験において具体化 した原理がより日常的に実施し得る、大量生産に適した培養皿を設計した。Furthermore, the imperfectly balanced surface tension between the central microdroplet and the outer ring causes the oocyte to It was found that it can damage cells. Therefore, as embodied in the mouse experiments mentioned above, We designed a culture dish suitable for mass production, in which the principle described above can be implemented more routinely.
第2図は、本発明の使用に特に適合せしめた培養皿の上面図を示す。この培養皿 において、2つの卵母細胞室4が、円形領域21の反対側で、培地の微小小滴の 縁を定義する壁部材22の内側に配されている。FIG. 2 shows a top view of a culture dish specifically adapted for use in the present invention. This culture dish , the two oocyte chambers 4 are placed on opposite sides of the circular area 21 in a microdroplet of medium. It is arranged inside the wall member 22 that defines the edge.
しかしながら、卵母細胞室の数が多く、2から60が体外受精の試みに適した通 常の卵母細胞の範囲であることが分かっている。However, the number of oocyte chambers is large and between 2 and 60 are suitable chambers for IVF attempts. It is known that this is within the range of normal oocytes.
中央円形領域21は好ましくは、隆起部32が中央円形領域21の中央と卵母細 胞室4の間に形成されるように中央くぼみ31(第3図)を育する。中央円形領 域21の直径は好ましくは、0.5から30mm、より好ましくはlOから20 mmである。The central circular region 21 preferably has a raised portion 32 between the center of the central circular region 21 and the oocyte thin layer. A central depression 31 (FIG. 3) is grown to be formed between the cell chambers 4. central circular area The diameter of the zone 21 is preferably between 0.5 and 30 mm, more preferably between 10 and 20 mm. It is mm.
使用に際して、培地の微小小滴を壁部材22内に配する。In use, a microdroplet of culture medium is placed within the wall member 22.
この微小小滴の容積は、中央円形領域21の直径、中央くぼみ31の深さ、およ び存在する場合には卵母細胞室4の容積と数に依存するが、一般的には約80か ら120μlである。The volume of this microdroplet is determined by the diameter of the central circular region 21, the depth of the central recess 31, and It depends on the volume and number of oocyte chambers 4, but generally there are about 80 or more oocyte cells. and 120 μl.
以下に記載するように、精子を導くために案内部材が存在する場合には、より大 きな容積を用いてもよい。卵母細胞33を卵母細胞室4中に配し、精子試料34 を中央円形領域21の中央に配する。中央円形領域21は、添加する精子の容積 の規定を補助するためにその領域に印刷されたリング24(第2図)を有しても よい。添加する精子の数は一般的に、8−12μmの容積で8.000から12 .000である。If a guide member is present to guide the sperm, as described below, the A larger volume may be used. An oocyte 33 is placed in the oocyte chamber 4, and a sperm sample 34 is placed in the oocyte chamber 4. is placed in the center of the central circular area 21. The central circular area 21 is the volume of sperm to be added. may have a ring 24 (Fig. 2) printed in that area to assist in the definition of good. The number of spermatozoa added is generally between 8.000 and 12 in a volume of 8-12 μm. .. It is 000.
精子を添加した後、壁部材22と重複するふた35を用いて、中央円形領域21 を覆ってもよい。次いでこの皿において、所定の期間(通常10から20時間) に亘り、健康な運動精子が中央円形領域の縁にある卵母細胞に泳いで行き、そこ に存在する卵母細胞と受精することを行なわせる。After adding the sperm, the central circular area 21 is closed using a lid 35 that overlaps the wall member 22. may be covered. This dish is then incubated for a predetermined period of time (usually 10 to 20 hours). During this period, healthy motile sperm swim to the oocyte at the edge of the central circular area, where it is deposited. to fertilize the oocytes present in the cells.
本発明による培養皿はまた、中央円形領域21の表面に配された案内部材26を 有してもよい。これらの案内部材は、卵母細胞が存在し、それゆえ受精の速度と 頻度を高める部分に向かって運動精子を導く傾向にある。好ましい案内部材は、 T型の断面図を有する(第4図)。案内部材を使用することにより、潜在的に有 用な1−2m1はどの容積で「微小小滴」において大容積を使用することができ る。The culture dish according to the invention also has a guide member 26 arranged on the surface of the central circular area 21. May have. These guide members are responsible for the presence of the oocyte and therefore for the speed and speed of fertilization. It tends to direct motile sperm toward areas of increased frequency. A preferred guide member is It has a T-shaped cross section (Fig. 4). By using guide members, potentially useful 1-2 m1 is the volume that can be used in "microdroplets". Ru.
本発明の卵母細胞室は、第3図に示すように、単純なくぼみであっても、または 渦の形状を有してもよい。後者の場合には、卵母細胞室は、200から5.OQ Q 、好ましくは400から1.000ミクロンの上面直径、200から2.0 00 、好ましくは200から500ミクロンの底面の直径、および150から i、ooo 、好ましくは150から500 ミクロンの深さを有する。The oocyte chamber of the present invention may be a simple depression, as shown in FIG. It may have the shape of a vortex. In the latter case, the oocyte chamber will contain between 200 and 5. OQ Q, preferably 400 to 1.000 microns top diameter, 200 to 2.0 00, preferably from 200 to 500 microns base diameter, and from 150 to i,ooo, preferably having a depth of 150 to 500 microns.
第1図に示した微小室形状はまた、例えば微小小滴の周囲の辺りのプラスチック 皿の表面上に上昇した縁を形成することにより設けることもできる。卵母細胞室 は、上述したようなこの上昇した縁またはくぼみに形成されるアネックスであっ てもよい。The microchamber shape shown in Figure 1 also allows for e.g. It can also be provided by forming a raised rim on the surface of the dish. oocyte chamber is an annex formed in this raised rim or depression as described above. It's okay.
IVF工程において活発に関連する、上述した要素に加えて、室は、蒸発を低減 する水蒸気供給源を提供するために室の回りに溝(well)を含んでもよい。In addition to the above-mentioned factors that are actively involved in the IVF process, the chamber reduces evaporation. A well may be included around the chamber to provide a source of water vapor.
溝は微小室とは隣接していないが、微小室に沿って覆いの下に位置する。The grooves are not adjacent to the microchambers, but are located along the microchambers and under the cover.
本発明の方法は、ヒトの卵母細胞並びに動物からの卵母細胞の体外受精を行なう のに有用である。これらの卵母細胞は、直径で約80から約150ミクロンに亘 る様々なサイズを有する。例えば、ヒトの卵母細胞は一般的に、直径で約120 ミクロンであるが、マウスとラットからの卵母細胞は一般的に直径で約80ミ クロンである。ここに使用している「卵母細胞」という用語は、ともに回収され て分離できない卵母細胞の小さなりラスターまたは周囲の卵丘細胞を有する卵母 細胞を包含してもよい。The method of the present invention performs in vitro fertilization of human oocytes as well as oocytes from animals. It is useful for These oocytes range in diameter from about 80 to about 150 microns. Available in a variety of sizes. For example, human oocytes typically have diameters of about 120 microns, but oocytes from mice and rats are generally about 80 mm in diameter. It's Kron. The term "oocyte" as used herein refers to both oocytes with a small raster of oocytes or surrounding cumulus cells that cannot be separated by It may also include cells.
受精せしめられる卵母細胞は、例えば標準受精の卵子の装填に通常用いられるよ うな微量ピペットにより、卵母細胞室に手動で配される。卵母細胞室は、受精せ しめられる卵母細胞の特定の種に合わせて作られている。卵母細胞への損傷を避 けて能率的な受精を行なうために、室の容積は一般的に、卵母細胞の容積の80 0から2.(100%である。ヒトを含む、様々な種への使用に適した室サイズ は、直径200μ×深さ400μの寸法を有する。The oocytes to be fertilized are e.g. The oocyte is manually placed into the oocyte chamber using a micropipette. The oocyte chamber is used for fertilization. It is tailored to the specific species of oocyte being incubated. Avoid damage to oocytes To ensure efficient fertilization, the volume of the chamber is generally 80% of the oocyte volume. 0 to 2. (100%. Chamber size suitable for use with various species, including humans) has dimensions of 200μ diameter x 400μ depth.
培養皿内に用いる特定の培地は重要ではなく、特定の種に適している二とが知ら れているいかなる培地を用いてもよい。例えば、表2に示したヒト培地を用いて 好結果が得られた。The particular medium used in the culture dish is not critical; only one is known to be suitable for a particular species. Any culture medium may be used. For example, using the human medium shown in Table 2 Good results were obtained.
実施例1 はとんどのマウスの精子は冷凍すると生存できないので、冷凍−解凍マウスの精 子を用いて、第1図に示したような原型装置の効用を研究した。この試験におい て、ゴートン等、J、 Exp、 Zoo 1.239.347 (1986) に記載されているように、いくつかの運動精子が卵母細胞を貫通するのを補助す るためにその卵母細胞を帯穴開けしくzona drilled)、表3に示し た受精培地の微小小滴中に形成された卵母細胞室に卵母細胞それぞれを配した。Example 1 Most mouse sperm cannot survive when frozen, so frozen-thawed mouse sperm cannot survive. The effectiveness of the prototype device shown in Figure 1 was studied using a child. This test smell Gorton et al., J. Exp. Zoo 1.239.347 (1986) helps some motile sperm penetrate the oocyte, as described in The oocytes were drilled (zona drilled) and shown in Table 3. Each oocyte was placed in an oocyte chamber formed in a microdroplet of fertilization medium.
次いで10μlの冷凍−解凍精子の試料をその微小小滴の中央に配した。運動精 子の割合が5%未満である5つの実験において、平均65%(53−76%の範 囲)の受精が達成できた。A 10 μl sample of frozen-thawed sperm was then placed in the center of the microdroplet. athleticism In five experiments where the proportion of offspring was less than 5%, the mean was 65% (range 53-76%). The fertilization (circle) was achieved.
F−10イーグル培地 (lx) (lx) 成 分(ig/L) 無機塩: CaC1□ (無水> 200.00 CaC12” 2H2044,1−− CuSO4” 5H20’ 0.0025 −F e SO4’ 7H200, 834−−K Cl 2g5.0 400.00 KB2 PO4g3.0 −− Mg Soa ’ 7H20152,8200,0ON a Cl 7400. 0 6800.0ON a HCO31200,02200,0ONaHzPO 4”HzO++ 140.0ON a 2 HP 04 ・7 H20290, OZ n S 04 ” 7 H200,0288他の成分: D−グルコース11G0.0 1000.cl。F-10 Eagle medium (lx) (lx) Component (ig/L) Inorganic salt: CaC1□ (Anhydrous>200.00 CaC12” 2H2044,1-- CuSO4" 5H20' 0.0025 -F e SO4' 7H200, 834--K Cl 2g5.0 400.00 KB2 PO4g3.0 -- Mg Soa’ 7H20152,8200,0ON a Cl 7400. 0 6800.0ON a HCO31200,02200,0ONaHzPO 4”HzO++ 140.0ON a 2 HP 04/7 H20290, OZ n S 04 ”7 H200,0288Other ingredients: D-glucose 11G0.0 1000. cl.
ヒポキサンチン 4.0 − リポ酸 0.2 − フェノールレッド 1.2 to、o。Hypoxanthine 4.0 - Lipoic acid 0.2 - Phenol red 1.2 to, o.
ピルビン酸ナトリウム 110.0 チミジン 0.7 L−アルギニン − 17.40 L−7hギニ>EC1211,0− L−アスパラギン・HzO15,01 L−アスパラギン酸 13.O L−システィン 25.0 L−シスチン −12,00 L−グルタミン酸 14.7 L−グルタミン 148.0G 292.00グリシン 7.51 L−ヒスチジン 8.00 L hスチシ:/HCl ・H2023,OL−イソロイシン 2.6 26. 0OL−ロイシン 13.0 26.0O L−リジン 29.2O L−リシンHCI 29.0 − L−メチオニン 7.5O L−フェニルアラニン 16.5O L−スレオニン 24.00 L−)リブトファン 4.0O L−チロシン 18.0O L−チロシン(2ナトリウム塩)− L−バリン 23.50 ビタミン: ビオチン 0.024 1.00 重酒石酸コリン l、00 塩酸コリン 0.698 1.00 葉酸 1.32 1.00 1−イノシタル 0.541 2.00ニコチンアミド 1.00 ピリドキサールHCI 1.00 リボフラビン 0.37B 0.10 チアミンHC11,001,QO D−Ca−パントテン酸塩 0.715ナイアシンアミド 0.815 ピロトキシンHCI 0.206 ビタミンB、□ 163B 表 3 NaC1(vリンクOyト審7851) 5.14グラムKCI(ベーカ−$1 −3040) 0.38グラムKH2PO4(7リンクO−/ト$7100) 0.18グラムMg5O,−7H20 (マリンクロット零808B) 0.29グラムN a HCOi (フィッシ ャー審S−233) 2.11グラムピルビン酸Na(シュヮル゛ンーマン審9 04144)0.04グラムグルコース(フィッシャー零〇−18) 1.00 グラムペニシリンG、 K塩 (シュワルツ−マン婁4049) 0.75グラムストレプトマイシン硫酸塩 (シュワルツ−マン霧3242) 0.05グラムこれらの成分をフラスコ中に 重りとり、9951の二重蒸留H20を加え、溶解するまで撹拌する。次いで、 乳酸ナトリウム60%、ファンスティールラボ 3.68m17 工/ −ルL /−/ド、1%溶液(ディ7 :45358−59)1.00m1を加える。こ れに3g/lの結晶性ウシ血清アルブミン(ベンテックスll8l−001−3 )を加え、溶解するまで撹拌する。Sodium pyruvate 110.0 Thymidine 0.7 L-arginine - 17.40 L-7h Gini>EC1211,0- L-asparagine・HzO15,01 L-aspartic acid 13. O L-cystine 25.0 L-cystine -12,00 L-glutamic acid 14.7 L-glutamine 148.0G 292.00 Glycine 7.51 L-Histidine 8.00 L h :/HCl ・H2023, OL-isoleucine 2.6 26. 0OL-Leucine 13.0 26.0O L-lysine 29.2O L-lysine HCI 29.0 - L-methionine 7.5O L-phenylalanine 16.5O L-threonine 24.00 L-) Ributofan 4.0O L-tyrosine 18.0O L-tyrosine (disodium salt)- L-valine 23.50 vitamin: Biotin 0.024 1.00 Choline bitartrate l, 00 Choline hydrochloride 0.698 1.00 Folic acid 1.32 1.00 1-Inocital 0.541 2.00 Nicotinamide 1.00 Pyridoxal HCI 1.00 Riboflavin 0.37B 0.10 Thiamin HC11,001,QO D-Ca-pantothenate 0.715 Niacinamide 0.815 Pyrotoxin HCI 0.206 Vitamin B, □ 163B Table 3 NaC1 (v-link Oyto 7851) 5.14g KCI (Baker-$1 -3040) 0.38g KH2PO4 (7 links O-/to $7100) 0.18g Mg5O, -7H20 (Marinckrodt Zero 808B) 0.29g N a HCOi (Fissi Judge S-233) 2.11 g Sodium pyruvate (Schwarzenman Judge 9 04144) 0.04g glucose (Fisher 0-18) 1.00 Grampenicillin G, K salt (Schwartzman Lou 4049) 0.75g streptomycin sulfate (Schwartzmann Mist 3242) 0.05 grams of these ingredients in a flask Add weight and 9951 double distilled H20 and stir until dissolved. Then, Sodium lactate 60%, Funsteel Lab 3.68m17 Eng/L Add 1.00 ml of 1% solution (D7:45358-59). child 3 g/l of crystalline bovine serum albumin (Ventex ll8l-001-3) ) and stir until dissolved.
この培地を、殺菌のために0.22ミクロンのミリポアフィルタ−で濾過する。The medium is filtered through a 0.22 micron Millipore filter for sterilization.
これを4℃で貯蔵してもよい。This may be stored at 4°C.
比較を行なうために、帯穴開けしたマウスの卵母細胞を、2mlの組織器(ti ssue dish)中の同一容積の冷凍−解凍精子に露出した。この環境では 、おそらくは、多くの非運動精子が卵母細胞への接近を妨げたので、受精率はた ったの10%であった。For comparison, band-punctured mouse oocytes were placed in a 2 ml tissue vessel (ti The cells were exposed to the same volume of frozen-thawed spermatozoa in a ssue dish). In this environment , the fertilization rate was probably low because many non-motile spermatozoa blocked access to the oocyte. It was 10% of the total.
本発明の培養皿中の体外受精の改良能率は、精子の冷凍保存により、遺伝子導入 系統のような価値のあるマウス系統を保存することを可能にする。それゆえ本発 明は、価値ある動物の系統の管理における価値ある手段を証明する。The improved efficiency of in vitro fertilization in the culture dish of the present invention is achieved by cryopreservation of spermatozoa and gene transfer. This makes it possible to preserve valuable mouse strains such as strains. Therefore, the original Ming proves a valuable tool in the management of valuable animal strains.
実施例2 6か月以上も不妊であることが証明されている精管切除した雄のマウスからの精 子を、第1図に示したような造形微小小滴中で試験した。合計で30の卵母細胞 を、卵母細胞室中に配し、10μmの未分別精子の試料を添加した。受精培地は 表3に示したものであった。Example 2 Semen from vasectomized male mice that have been proven infertile for more than 6 months The particles were tested in shaped microdroplets as shown in FIG. 30 oocytes in total were placed in the oocyte chamber and a 10 μm sample of unsorted spermatozoa was added. The fertilization medium is The results are shown in Table 3.
非常にわずかな自由遊泳精子しか存在しない1つの実験を含む2つの実験におい て、受精能率は100%であった。In two experiments, including one experiment in which very few free-swimming sperm were present. The fertilization efficiency was 100%.
それとは対称的に、106の運動精子を2mlの培養培地の皿に添加したときに 、同一の精子試料を用いて、たったの7%の卵母細胞が受精せしめられた。In contrast, when 106 motile spermatozoa were added to a dish with 2 ml of culture medium, , only 7% of oocytes were fertilized using the same sperm sample.
これらの結果は、本発明が、運動精子の割合が非常に低い、すなわち<10%で ある場合にも受精能率を改善できることを示している。本発明は、先天性精管欠 如または失敗した精管切除の修復のような臨床状況に特に有用であるのが分かる 。さらに、分別が不必要であるので、本発明を使用すると、体外受精の「手順」 を簡素化できる。These results demonstrate that the present invention has a very low percentage of motile spermatozoa, i.e. <10%. It has been shown that fertility can be improved in some cases. The present invention is a method for treating congenital vas deferens. may prove particularly useful in clinical situations such as the repair of a failed or failed vasectomy. . Furthermore, since separation is unnecessary, using the present invention the IVF "procedure" can be simplified.
実施例3 先天性精管欠如のヒトの患者から得た精子試料で卵母細胞を受精せしめるのに、 第1図の微小室を用いた。回収と洗浄の後、この試料は、約5%の運動性がある 1×106の精子を有し、血液でひどく汚染されていた。微小路質中の2つの卵 母細胞を受精するために分別していない洗浄試料を用い、残りの試料をバーコル 技術を用いて分別した。Example 3 To fertilize oocytes with sperm samples obtained from human patients with congenital absence of vas deferens, The microchamber shown in Figure 1 was used. After collection and washing, this sample is approximately 5% motile. It had 1 x 106 spermatozoa and was heavily contaminated with blood. Two eggs in the micropathology Use the unfractionated washed sample to fertilize the mother cells and barcol the remaining sample. Separated using technology.
バーコル分別した後、微小室中に配されない卵母細胞の受精には、運動精子は回 収されなかった。しかしながら、微小室中の2つの卵子のうち1つ(50%)は 、未分別標品で受精せしめられ、受精卵移植を行なった。After Barcol sorting, motile spermatozoa are used for fertilization of oocytes that are not placed in microchambers. It was not collected. However, one out of two eggs in the microchamber (50%) The embryos were fertilized with unsorted specimens, and fertilized eggs were transplanted.
実施例4 他の研究において、第1図の微小室中にヒト卵子を装填することにより標準受精 を行なった。精子を洗浄または希釈し、直接室に添加した。受精率を、「スイム −アップ」方法後の2m1皿中の通常対照受精と比較した。射出精液中に5ox to6の運動精子を有する1人の患者において、精子は単に希釈し、微小室中に 配した。2回の洗浄後にスイムアップを行なったが、この方法にはほぼ2時間を 要し、結果として著しく精子を損失した。結果は、微小室(2/4の卵子が受精 した)のほうが対照(1/6が受精した)より良好であり、それゆえ、微小室は 、時間、出費および洗浄と分別に関連する精子の損失を低減できることを示して いる。Example 4 In other studies, standard fertilization was achieved by loading human eggs into the microchamber shown in Figure 1. I did this. Sperm were washed or diluted and added directly to the chamber. Fertility Comparisons were made with normal control fertilization in 2 ml dishes after the "-Up" method. 5ox in ejaculate semen In one patient with to6 motile sperm, the sperm were simply diluted and placed into the microchamber. Arranged. I did a swim-up after washing twice, and this method took about 2 hours. This resulted in a significant loss of sperm. The result is that the microchamber (2/4 of the eggs are fertilized) fertilized) than the control (1/6 fertilized), therefore the microchambers , have shown that the time, expense and loss of sperm associated with washing and sorting can be reduced. There is.
いくつかの付加実験において、精子を洗浄し、分別せずに微小室で用いた。微小 室の受精率(9/28.32%)は、対照器の受精率(1515B、27%)と 同様であり、再度微小室を用いると分別の必要がなくなることを示した。In some additional experiments, sperm were washed and used in the microchamber without fractionation. tiny The fertilization rate of the chamber (9/28.32%) is the same as the fertilization rate of the control vessel (1515B, 27%). The results were similar, indicating that if a microchamber was used again, the need for separation was eliminated.
前述した議論と実施例は、本発明の方法と装置の根本的なパラメータを述べたも のである。しかしながら、他の形状もまた用いられることも明確である。例えば 、第5図に示すように、精子を装填する環状の溝52により囲まれた中央プラト ー領域51上に配された1つ以上の卵母細胞4を有する培養皿もまた本発明の方 法に用いられる。中央プラトー51は好ましくは、底部の内面より低い表面水準 を有する。The foregoing discussion and examples describe the fundamental parameters of the method and apparatus of the present invention. It is. However, it is clear that other shapes can also be used. for example , a central plate surrounded by an annular groove 52 into which sperm are loaded, as shown in FIG. - A culture dish with one or more oocytes 4 arranged on the region 51 is also a subject of the invention. used in law. The central plateau 51 preferably has a lower surface level than the inner surface of the bottom. has.
FIG、1 FIG、 3 FIG、 4FIG.1 FIG.3 FIG. 4
Claims (14)
Applications Claiming Priority (3)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
US69974591A | 1991-05-14 | 1991-05-14 | |
US699,745 | 1991-05-14 | ||
PCT/US1992/003939 WO1992020359A1 (en) | 1991-05-14 | 1992-05-08 | Method and apparatus for in vitro fertilization |
Publications (1)
Publication Number | Publication Date |
---|---|
JPH06507565A true JPH06507565A (en) | 1994-09-01 |
Family
ID=24810712
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
JP5500135A Pending JPH06507565A (en) | 1991-05-14 | 1992-05-08 | IVF methods and devices |
Country Status (5)
Country | Link |
---|---|
US (1) | US5512476A (en) |
EP (1) | EP0585349A4 (en) |
JP (1) | JPH06507565A (en) |
AU (1) | AU2016392A (en) |
WO (1) | WO1992020359A1 (en) |
Families Citing this family (19)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US5627066A (en) * | 1991-05-14 | 1997-05-06 | Mount Sinai School Of Medicine Of The City University Of New York | Method and apparatus for in vitro fertilization |
FR2709250B1 (en) * | 1993-08-23 | 1995-10-13 | Ccd Laboratoire | Device for selecting sperm. |
US6156566A (en) * | 1997-10-17 | 2000-12-05 | Bryant; Debra L. | In vitro fertilization procedure dish |
US6357596B1 (en) | 1997-12-19 | 2002-03-19 | Machelle Seibel | Sperm strainer system |
US6673008B1 (en) | 1998-04-28 | 2004-01-06 | Ronald J. Thompson | Fallopian tube and method of in vitro fertilization and embryo development |
US6193647B1 (en) * | 1999-04-08 | 2001-02-27 | The Board Of Trustees Of The University Of Illinois | Microfluidic embryo and/or oocyte handling device and method |
AU5061300A (en) * | 1999-06-30 | 2001-01-22 | Danish Institute of Agricultural Sciences, The | Microchamber for embryo cell culture |
GB0114849D0 (en) * | 2001-06-18 | 2001-08-08 | Pig Improvement Co Uk Ltd | System |
GB0115104D0 (en) * | 2001-06-20 | 2001-08-15 | Abed Farhang | Apparatus for and methods of in vitro fertilization |
GB0115103D0 (en) * | 2001-06-20 | 2001-08-15 | Abed Farhang | Apparatus for and methods of preparing sperm |
JP2008512990A (en) | 2004-05-17 | 2008-05-01 | ザ ジェネラル ホスピタル コーポレーション | Methods and compositions for producing germ cells from germline stem cells derived from bone marrow |
JP5451073B2 (en) | 2005-10-14 | 2014-03-26 | ユニセンス・ファーティリテック・アクティーゼルスカブ | Determining changes in cell populations |
ES2363406T3 (en) | 2007-06-29 | 2011-08-03 | Unisense Fertilitech A/S | DEVICE, SYSTEM AND METHOD FOR MONITORING AND / OR CULTIVATING MICROSCOPIC OBJECTS. |
US9157550B2 (en) * | 2009-01-05 | 2015-10-13 | The Board Of Trustees Of The University Of Illinois | Microfluidic systems and methods |
AU2012242591B2 (en) | 2011-04-14 | 2014-10-23 | The General Hospital Corporation | Compositions and methods for autologous germline mitochondrial energy transfer |
EP2726601B1 (en) | 2011-06-29 | 2018-12-26 | The General Hospital Corporation | Compositions and methods for enhancing bioenergetic status in female germ cells |
US20160354781A1 (en) * | 2015-06-08 | 2016-12-08 | National Taiwan University | Microfluidic plate for sample processing |
KR101711105B1 (en) * | 2016-04-21 | 2017-03-06 | 주식회사 퀀타매트릭스 | Cell culture device in multi-well format for rapid antibiotic susceptibility test |
CN107723237B (en) * | 2017-11-23 | 2023-12-08 | 北京大学深圳医院 | Multipurpose culture dish for auxiliary reproduction test |
Family Cites Families (11)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
GB1536306A (en) * | 1975-10-06 | 1978-12-20 | British Steel Corp | Electronic monitoring apparatus |
US4321330A (en) * | 1980-04-04 | 1982-03-23 | Baker Fraser L | Tissue culture device |
US4349632A (en) * | 1981-03-17 | 1982-09-14 | Data Packaging Corporation | Tissue culture cluster dish |
US4377077A (en) * | 1981-07-15 | 1983-03-22 | Biotech Research Laboratories, Inc. | Device and method for controlled freezing of cell cultures |
US4772554A (en) * | 1985-01-24 | 1988-09-20 | Wisconsin Alumni Research Foundation | Ova fertilization assay |
US4725579A (en) * | 1985-02-21 | 1988-02-16 | Serono Laboratories, Inc. | Method of in vitro fertilization by a unique combination of gonadotropins |
US5026649A (en) * | 1986-03-20 | 1991-06-25 | Costar Corporation | Apparatus for growing tissue cultures in vitro |
US4975377A (en) * | 1987-05-14 | 1990-12-04 | Key Marc E | Cell growth chambers and method of use thereof |
US4987080A (en) * | 1987-11-03 | 1991-01-22 | Grob Howard S | Method for in vitro maturation of oocytes |
US4829006A (en) * | 1988-02-01 | 1989-05-09 | Difco Laboratories | Centrifugation vial and cluster tray |
US5002889A (en) * | 1988-10-21 | 1991-03-26 | Genetic Systems Corporation | Reaction well shape for a microwell tray |
-
1992
- 1992-05-08 AU AU20163/92A patent/AU2016392A/en not_active Abandoned
- 1992-05-08 EP EP19920912030 patent/EP0585349A4/en not_active Withdrawn
- 1992-05-08 WO PCT/US1992/003939 patent/WO1992020359A1/en not_active Application Discontinuation
- 1992-05-08 JP JP5500135A patent/JPH06507565A/en active Pending
-
1993
- 1993-09-22 US US08/125,084 patent/US5512476A/en not_active Expired - Fee Related
Also Published As
Publication number | Publication date |
---|---|
WO1992020359A1 (en) | 1992-11-26 |
AU2016392A (en) | 1992-12-30 |
US5512476A (en) | 1996-04-30 |
EP0585349A4 (en) | 1994-12-07 |
EP0585349A1 (en) | 1994-03-09 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
JPH06507565A (en) | IVF methods and devices | |
Cohen et al. | Cryopreservation of single human spermatozoa. | |
Gook et al. | Cryopreservation of mouse and human oocytes using 1, 2-propanediol and the configuration of the meiotic spindle | |
Choi et al. | Equine blastocyst development after intracytoplasmic injection of sperm subjected to two freeze-thaw cycles | |
Rezazadeh Valojerdi et al. | Vitrification versus slow freezing gives excellent survival, post warming embryo morphology and pregnancy outcomes for human cleaved embryos | |
Sutovsky et al. | Intracytoplasmic sperm injection for Rhesus monkey fertilization results in unusual chromatin, cytoskeletal, and membrane events, but eventually leads to pronuclear development and sperm aster assembly | |
US5691194A (en) | Method and apparatus for in vitro fertilization | |
Kishikawa et al. | Fertility of mouse spermatozoa retrieved from cadavers and maintained at 4 C | |
Chauhan et al. | In vitro maturation and fertilization, and subsequent development of buffalo (Bubalus bubalis) embryos: effects of oocyte quality and type of serum | |
Desai et al. | The new Rapid-i carrier is an effective system for human embryo vitrification at both the blastocyst and cleavage stage | |
Antinori et al. | Successful fertilization and pregnancy after injection of frozen-thawed round spermatids into human oocytes. | |
Endo et al. | Single spermatozoon freezing using Cryotop | |
Bourne et al. | Sperm preparation for intracytoplasmic injection: methods and relationship to fertilization results | |
Windt et al. | Intracytoplasmic sperm injection with testicular spermatozoa in men with azoospermia | |
Jo et al. | Production of female bovine embryos with sex-sorted sperm using intracytoplasmic sperm injection: efficiency and in vitro developmental competence | |
Choi et al. | Effect of medium variations (zinc supplementation during oocyte maturation, perifertilization pH, and embryo culture protein source) on equine embryo development after intracytoplasmic sperm injection | |
US6132952A (en) | Storage system comprising an emptied zona pellucida and spermatozoa placed therein and a method of cryopreservation | |
Tucker et al. | Factors affecting success with intracytoplasmic sperm injection | |
Hasegawa et al. | Microdroplet in vitro fertilization can reduce the number of spermatozoa necessary for fertilizing oocytes | |
Sereni et al. | Freezing spermatozoa obtained by testicular fine needle aspiration: a new technique | |
Desai et al. | Vitrification of mouse embryo-derived ICM cells: a tool for preserving embryonic stem cell potential? | |
WO2018014692A1 (en) | Method for washing surface of ovum or fertilized ovum | |
Wang et al. | Developmental capacity of mechanically bisected mouse morulae and blastocysts | |
US6759244B2 (en) | Composite blastocysts (CBs) from aggregates of dissociated cells of non-viable pre-embryos | |
Van den Bergh et al. | Intracytoplasmic single sperm injection: preclinical training and first clinical results |